PCMTD2 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.61800017828284E-10 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.68570000000668E-06 |
Normal-vs-Stage2 |
1.437520E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.728140E-02 |
Stage1-vs-Stage2 |
6.897000E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
4.607400E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
6.907400E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62109999868321E-08 |
Normal-vs-AfricanAmerican |
1.821590E-01 |
Normal-vs-Asian |
8.7183000041513E-08 |
Caucasian-vs-AfricanAmerican |
3.300200E-01 |
Caucasian-vs-Asian |
6.292000E-01 |
AfricanAmerican-vs-Asian |
4.197400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.05940000000449E-05 |
Normal-vs-Female |
6.09439999577077E-08 |
Male-vs-Female |
2.741800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.376360E-03 |
Normal-vs-Extreme_Weight |
7.94210000000239E-05 |
Normal-vs-Obese |
3.280600E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
3.190000E-01 |
Normal_Weight-vs-Obese |
2.064200E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
7.672400E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.71310000002456E-06 |
Normal-vs-Age(41-60Yrs) |
7.778900E-04 |
Normal-vs-Age(61-80Yrs) |
8.72090000214598E-08 |
Normal-vs-Age(81-100Yrs) |
4.341600E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.001000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.416200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.784000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.427700E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.182600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.809400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
7.154800E-01 |
Normal-vs-Grade 3 |
7.317000E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.658600E-01 |
Grade 2-vs-Grade 4 |
7.154800E-01 |
Grade 3-vs-Grade 4 |
7.317000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.22130000451892E-08 |
Normal-vs-N1 |
2.112400E-02 |
N0-vs-N1 |
7.353800E-02 |
|
|